Molecular Typing
Showing 1 - 25 of 5,179
Advanced Salivary Gland Carcinoma Trial in Shanghai (SHR-A1811, SHR 3680 + leuprolide, SHR-A1921)
Not yet recruiting
- Advanced Salivary Gland Carcinoma
- SHR-A1811
- +2 more
-
Shanghai, ChinaDongmei Ji
Jun 21, 2023
To EstablishMolecular Typing System for Early Diagnosis of Lung
Recruiting
- Lung Cancer
-
Beijing, Beijing, ChinaChina-Japan Friendship Hospital
Jun 20, 2022
Based on Molecular Typing of Medulloblastoma in Children
Not yet recruiting
- Medulloblastoma, Childhood
- Prospective observational study, no intervention
- (no location specified)
Jun 4, 2022
Breast Cancer, Molecular Typing, Pathology Trial in Shanghai (Multidisciplinary cooperative comprehensive treatment)
Not yet recruiting
- Breast Cancer
- +3 more
- Multidisciplinary cooperative comprehensive treatment
-
Shanghai, Shanghai, ChinaFudan University Shanghai Cancer Center
Aug 20, 2020
Obesity-related Molecular Typing and Traditional Chinese
Unknown status
- Obstructive Sleep Apnea
- Obesity
- blood test
- +5 more
-
Taoyuan, TaiwanChang Gung Memorial hospital
Jul 14, 2020
"High Risk" Molecular Typing in Adult T Lymphoblastic Lymphoma
Recruiting
- T-Lymphoblastic Lymphoma/Leukemia
-
Guangzhou, ChinaSun Yat-Sen Memorial Hospital, Sun Yat-Sen University,
Mar 25, 2020
Molecular Typing and Neoadjuvant Chemotherapy in Breast Cancer
Unknown status
- Evaluation of the Value of Mammaprint Test Gene Variation in the Prediction of Neoadjuvant Chemotherapy for Breast Cancer
- neoadjuvant chemotherapy
-
Hangzhou, Zhejiang, ChinaZhejiang Cancer Hospital
Feb 10, 2020
MRI Radiomics Combined With Pathomics on Prediction of Molecular
Not yet recruiting
- Endometrial Neoplasms
- next generation sequencing AND Immunohistochemical examination
-
Fuzhou, Fujian, ChinaClinical Oncology School of Fujian Medical University, Fujian Ca
Nov 13, 2023
Endometrial Carcinoma, Tumor Molecular Features Screening Model Trial (open surgery, laparoscopic surgery)
Not yet recruiting
- Endometrial Carcinoma
- Tumor Molecular Features Screening Model
- open surgery
- laparoscopic surgery
- (no location specified)
Jun 7, 2023
HR+/HER2-breast Cancer Trial (Standard endocrine therapy plus Apatinib)
Not yet recruiting
- HR+/HER2-breast Cancer
- Standard endocrine therapy plus Apatinib
- (no location specified)
Jun 2, 2023
NK-T-Cell Lymphoma, Extranodal Trial (Pegaspargase Combined With Gemcitabine, Etoposide, Liposomal Mitoxantrone Hydrochloride
Not yet recruiting
- NK-T-Cell Lymphoma, Extranodal
- Pegaspargase Combined With Gemcitabine, Etoposide, Liposomal Mitoxantrone Hydrochloride and Dexamethasone (P-GEMD) regimen
- (no location specified)
Mar 7, 2023
Molecular Subtyping of Extensive Stage Small Cell Lung Cancer
Recruiting
- SCLC,Extensive Stage
- PD-(L)1 antibody immunotherapy
-
Beijing, Beijing, ChinaPeking University Cancer Hospital & Institute
Jul 3, 2023
Triple-negative Breast Cancer Trial in Shanghai (A1: SHR-A1811, A2: SHR-A1811 with Camrelizumab, B1: TROP2 ADC)
Not yet recruiting
- Triple-negative Breast Cancer
- A1: SHR-A1811
- +11 more
-
Shanghai, ChinaFudan University Shanghai Cancer Center
Feb 19, 2023
Biliary Tract Diseases, Gallbladder Cancer, Extrahepatic Bile Duct Cancer Trial (no interventions)
Not yet recruiting
- Biliary Tract Diseases
- +5 more
- no interventions
- (no location specified)
Jun 1, 2023
Gastric Cancer, Multi-omics, Diagnosis Trial in Hangzhou (Without any intervention)
Active, not recruiting
- Gastric Cancer
- +2 more
- Without any intervention
-
Hangzhou, Zhejiang, ChinaCancer Hospital of the University of Chinese Academy of Sciences
Nov 15, 2023
Human Leukocyte Antigen Typing and Tumor Antigen Expression
Recruiting
- Refractory Cancer
- +3 more
-
Chicago, Illinois
- +3 more
Feb 14, 2022
Breast Tumor, Breast Cancer, Breast Tumors Trial in Shanghai (Dalpiciclib, Pyrotinib, SHR-A1811)
Not yet recruiting
- Breast Neoplasm
- +9 more
- Dalpiciclib
- +15 more
-
Shanghai, Shanghai, ChinaFudan University Shanghai Cancer Center Shanghai, China, 200032
Oct 13, 2022
Cutibacterium Acnes Infection Trial in France (5% benzoyl peroxide)
Recruiting
- Cutibacterium Acnes Infection
- 5% benzoyl peroxide
-
Angers, France
- +9 more
Jan 9, 2023
Blastocystis Hominis as Apotential Human Pathogen
Not yet recruiting
- Blastocystis Hominis Infections
- culture and PCR
- (no location specified)
Apr 14, 2023
Diffuse Large B-cell Lymphoma Trial (Rituximab, Mitoxantrone HCl liposome, Isophosphamide)
Not yet recruiting
- Diffuse Large B-cell Lymphoma
- Rituximab
- +7 more
- (no location specified)
Mar 23, 2023
Breast Cancer, Advanced Breast Cancer Trial in Shanghai (Everolimus 10 mg, CDK4/6 Inhibitor SHR6390, Aromatase inhibitor and
Not yet recruiting
- Breast Cancer
- Advanced Breast Cancer
- Everolimus 10 mg
- +2 more
-
Shanghai, Shanghai, ChinaFudan University Shanghai Cancer Center
Jul 14, 2023
comPuter Algorithm To Report BreAst cAncers (CLEOPATRAA)
Not yet recruiting
- Breast Cancer
- QPlasia OncoReader Breast (QPORB)
-
Leeds, West Yorkshire, United KingdomSt James's University Hospital, Leeds Teaching Hospitals Trust
Oct 26, 2023
Prognosis of Chronic Rhinosinusitis Based on Image and
Recruiting
- Chronic Sinusitis
- +4 more
- endoscopic sinus surgery
-
Wuhan, Hubei, ChinaDepartment of ENT, Tongji Hospital, Tongji Medical College, Huaz
Aug 8, 2023
